Quality of life of sarcopenic patients: contribution of the SarcoPhAge study

被引:6
作者
Beaudart, Charlotte [1 ]
Reginster, Jean-Yves [1 ]
Petermans, Jean [2 ]
Bruyere, Olivier [1 ]
机构
[1] Univ Liege, Dept Sci Sante Publ, B-4000 Liege, Belgium
[2] CHU Liege, Serv Geriatrie, Liege, Belgium
来源
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT | 2015年 / 13卷 / 04期
关键词
sarcopenia; quality of life; SarcoPhAge; MUSCLE; ASSOCIATION; PREVALENCE; MOBILITY; OBESITY; EUROQOL; INDEX; SF-36; STATE;
D O I
10.1684/pnv.2015.0571
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The consequences of sarcopenia on quality are difficult to evaluate and consequently are quite poorly studied. The few studies assessing the quality of life in sarcopenic subjects currently use generic quality of life questionnaires such as SF-36 and EQ-5D. The SarcoPhAge study, conducted on a cohort developed in Liege including 534 subjects of 65 years or older, suggested that sarcopenic subjects present a significant worse quality of life in the domains of physical function compared to non-sarcopenic subjects. Generic tools do not cover exhaustively all the areas of potential dysfunction concerned in this geriatric syndrome. Yet, there is no specific and validated quality of life questionnaire for sarcopenia. It would be useful to have at our disposal a sarcopenia specific quality of life questionnaire to assess not only the prospective quality of life of sarcopenic subjects but also to assess the efficacy and the relevance of new therapeutic and preventive strategies developed in the field of sarcopenia.
引用
收藏
页码:391 / 395
页数:5
相关论文
共 29 条
[1]   CONSTRUCT-VALIDATION AND THE RASCH MODEL - FUNCTIONAL ABILITY OF HEALTHY ELDERLY PEOPLE [J].
AVLUND, K ;
KREINER, S ;
SCHULTZLARSEN, K .
SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE, 1993, 21 (04) :233-245
[2]   Quality of life and physical components linked to sarcopenia: The SarcoPhAge study [J].
Beaudart, C. ;
Reginster, J. Y. ;
Petermans, J. ;
Gillain, S. ;
Quabron, A. ;
Locquet, M. ;
Slomian, J. ;
Buckinx, F. ;
Bruyere, O. .
EXPERIMENTAL GERONTOLOGY, 2015, 69 :103-110
[3]   Estimation of sarcopenia prevalence using various assessment tools [J].
Beaudart, C. ;
Reginster, J. Y. ;
Slomian, J. ;
Buckinx, F. ;
Dardenne, N. ;
Quabron, A. ;
Slangen, C. ;
Gillain, S. ;
Petermans, J. ;
Bruyere, O. .
EXPERIMENTAL GERONTOLOGY, 2015, 61 :31-37
[4]  
Beaudart C, 2014, J MUSCULOSKEL NEURON, V14, P425
[5]  
Beaudart C, 2015, AGE AGEING
[6]  
Beaudart C, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-45
[7]   Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort [J].
Bijlsma, A. Y. ;
Meskers, C. G. M. ;
Ling, C. H. Y. ;
Narici, M. ;
Kurrle, S. E. ;
Cameron, I. D. ;
Westendorp, R. G. J. ;
Maier, A. B. .
AGE, 2013, 35 (03) :871-881
[8]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[9]   Endocrine Crosstalk Between Muscle and Bone [J].
Brotto, Marco ;
Johnson, Mark L. .
CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (02) :135-141
[10]   Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) [J].
Cruz-Jentoft, Alfonso J. ;
Landi, Francesco ;
Schneider, Stephane M. ;
Zuniga, Clemente ;
Arai, Hidenori ;
Boirie, Yves ;
Chen, Liang-Kung ;
Fielding, Roger A. ;
Martin, Finbarr C. ;
Michel, Jean-Pierre ;
Sieber, Cornel ;
Stout, Jeffrey R. ;
Studenski, Stephanie A. ;
Vellas, Bruno ;
Woo, Jean ;
Zamboni, Mauro ;
Cederholm, Tommy .
AGE AND AGEING, 2014, 43 (06) :748-759